Evotec and Sanofi partner on beta cell therapy for diabetes
Evotec AG and Sanofi agreed to develop a beta cell replacement therapy for diabetes.
- Drug Discovery Technologies
- Gene Therapy, Cell Therapy
- Large Molecule
- Includes Royalty or Profit Split Information
- R&D and Marketing (Licensing)
Please contact Sales at: (212) 520-2765 or email [email protected]
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.